Abstract:Background: Clear cell renal cell carcinoma (ccRCC) is the main component of renal cell carcinoma (RCC), and advanced ccRCC frequently indicates a poor prognosis. The significance of the CCCH-type zinc finger (CTZF) gene in cancer has been increasingly demonstrated during the past few years. According to studies, targeted radical therapy for cancer treatment may be a revolutionary therapeutic approach. Both lncRNAs and CCCH-type zinc finger genes are essential in ccRCC. However, the predictive role of long non-coding RNA (lncRNA) associated with the CCCH-type zinc finger gene in ccRCC needs further elucidation. This study aims to predict patient prognosis and investigate the immunological profile of ccRCC patients using CCCH-type zinc finger-associated lncRNAs (CTZFLs). Methods: From the Cancer Genome Atlas database, RNA-seq and corresponding clinical and prognostic data of ccRCC patients were downloaded. Univariate and multivariate Cox regression analyses were conducted to acquire CTZFLs for constructing prediction models. The risk model was verified using receiver operating characteristic curve analysis. The Kaplan-Meier method was used to analyze the overall survival (OS) of high-risk and low-risk groups. Multivariate Cox and stratified analyses were used to assess the prognostic value of the predictive feature in the entire cohort and different subgroups. In addition, the relationship between risk scores, immunological status, and treatment response was studied. Results: We constructed a signature consisting of eight CTZFLs (LINC02100, AC002451.1, DBH-AS1, AC105105.3, AL357140.2, LINC00460, DLGAP1-AS2, AL162377.1). The results demonstrated that the prognosis of ccRCC patients was independently predicted by CTZFLs signature and that the prognosis of high-risk groups was poorer than that of the lower group. CTZFLs markers had the highest diagnostic adequacy compared to single clinicopathologic factors, and their AUC (area under the receiver operating characteristic curve) was 0.806. The overall survival of high-risk groups was shorter than that of low-risk groups when patients were divided into groups based on several clinicopathologic factors. There were substantial differences in immunological function, immune cell score, and immune checkpoint expression between high- and low-risk groups. Additionally, Four agents, including ABT737, WIKI4, afuresertib, and GNE 317, were more sensitive in the high-risk group. Conclusion: The Eight-CTZFLs prognostic signature may be a helpful prognostic indicator and may help with medication selection for clear cell renal cell carcinoma.

ASNS Can Predict the Poor Prognosis of Clear Cell Renal Cell Carcinoma

Prognostic model for clear-cell renal cell carcinoma based on natural killer cell-related genes.

LncRNA CCDC144NL-AS1 Serves As a Prognosis Biomarker for Non-small Cell Lung Cancer and Promotes Cellular Function by Targeting Mir-490-3p

The Correlation Between Novel Survival-related Alternative Splicing Signature and Prognostic Prediction and Immune Microenvironment in Clear Cell Renal Cell Carcinoma

Intratumoral CXCL13+CD8+T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma

Increased Expression of Colony Stimulating Factor-1 is a Predictor of Poor Prognosis in Patients with Clear-Cell Renal Cell Carcinoma

An Aging and Senescence-Related Gene Signature for Prognosis Prediction in Clear Cell Renal Cell Carcinoma

SAA1 Has Potential as a Prognostic Biomarker Correlated with Cell Proliferation, Migration, and an Indicator for Immune Infiltration of Tumor Microenvironment in Clear Cell Renal Cell Carcinoma

Prediction of clear cell renal cell carcinoma prognosis based on an immunogenomic landscape analysis

USP31 Serves As a Potential Biomarker for Predicting Prognosis and Immune Responses for Clear Cell Renal Cell Carcinoma Via Single-Cell and Bulk RNA-sequencing.

Identification of Prognostic Biomarkers for Clear Cell Renal Cell Carcinoma (ccrcc) by Transcriptomics.

SNX4 Is Correlated With Immune Infiltration and Prognosis in Clear Cell Renal Cell Carcinoma

Asparagine synthetase is an independent predictor of surgical survival and a potential therapeutic target in hepatocellular carcinoma

Integrative Bioinformatics Analysis Demonstrates the Prognostic Value of Chromatin Accessibility Biomarkers in Clear Cell Renal Cell Carcinoma

Identification of Prognosis Value and Immune Microenvironment Features of Cernas in NSCLC with Distinct Gene Mutation.

Decreased Expression of Long Non-Coding RNA NBAT-1 is Associated with Poor Prognosis in Patients with Clear Cell Renal Cell Carcinoma.

High SAA1 Expression Predicts Advanced Tumors in Renal Cancer

The prognostic implications and oncogenic role of NSUN5 in clear cell renal cell carcinoma

A New CCCH-type Zinc Finger-Related Lncrna Signature Predicts the Prognosis of Clear Cell Renal Cell Carcinoma Patients

The Overexpression of NUSAP1 and GTSE1 Could Predict An Unfavourable Prognosis and Shorter Disease Free Survival in ccRenal Cell Carcinoma

The Role of NCS1 in Immunotherapy and Prognosis of Human Cancer